Green tea-EGCG reduces GFAP associated neuronal loss in HIV-1 Tat transgenic mice

American Journal of Translational Research

Volumn 1, Issue 1, 2009, Pages 72-79

  Rrapo, Elona ^a   Zhu, Yuyan ^a   Tian, Jun ^a   Hou, Huayan ^a   Smith, Adam ^a   Fernandez, Francisco ^a   Tan, Jun ^a   Guinta, Brian ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

( ) Epigallocatechin 3 gallate (EGCG); Astrocytosis; Dementia; Green tea; HIV; Tat

Indexed keywords

DOXYCYCLINE; EPIGALLOCATECHIN GALLATE; GLIAL FIBRILLARY ACIDIC PROTEIN; GREEN TEA EXTRACT; MICROTUBULE ASSOCIATED PROTEIN 2; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTOSIS; BRAIN TISSUE; CELL LOSS; CELL SURVIVAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NERVE DEGENERATION; NONHUMAN; PROMOTER REGION; STAINING; TEA; TRANSGENIC MOUSE; WESTERN BLOTTING;

HUMAN IMMUNODEFICIENCY VIRUS 1; MUS MUSCULUS;

EID: 77953465939     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. An SF, Groves M, Giometto B, Beckett AA, Scaravilli F. Detection and localization of HIV-1 DNA and RNA in fixed adult AIDS brain by polymerase chain reaction/in situ hybridization technique. Acta Neuropathol 1999; 98: 481-487.
2. Nuovo GJ, Gallery F, MacConnell P, Braun A. In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-alpha RNA in the central nervous system. Am J Pathol. 1994;144: 659-666.
3. Saito Y, Sharer LR, Epstein LG, Michaels J, Mintz M, Louder M, Golding K, Cvetkovich TA, Blumberg BM. Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 1994; 44: 474-481.
4. Takahashi K, Wesselingh SL, Griffin DE, McArthur J, Johnson RT, Glass JD. Localization of HIV-1 in human brain using polymerase chain reaction/ in situ hybridization and immunocytochemistry. Ann Neurol 1996; 39: 705-711.
5. Thompson KA, Churchill MJ, Gorry PR, Sterjovski J, Oelrichs RB, Wesselingh SL, McLean CA. Astrocyte specific viral strains in HIV dementia. Ann Neurol 2004; 56: 873-877.
6. Tornatore C, Nath A, Amemiya K, Major EO. Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta. J Virol 1991; 65: 6094-6100.
7. Tornatore C, Chandra R, Berger JR, Major EO. HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 1994;44: 481-487.
8. Trillo-Pazos G, Diamanturos A, Rislove L, Menza T, Chao W. Detection of HIV-1 DNA in microglia/macrophages, astrocytes and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection. Brain Pathol 2003; 13: 144-154.
9. Pocernich CB, Boyd-Kimball D, Poon HF, Thongboonkerd V, Lynn BC, Klein JB, Calebrese V, Nath A, Butterfield DA, Proteomics analysis of human astrocytes expressing the HIV protein Tat. Mol Brain Res 2005; 133: 307-316.
10. Chen Y, Vartiainen NE, Ying W, Chan PH, Koistinaho J. Astrocytes protect neurons from nitric oxide toxicity by a glutathione dependent mechanism. J Neurochem 2001; 77: 1601-1610.
11. Tanaka J, Toku K, Zhang B, Ishihara K, Sakanaka M, Maeda N. Astrocytes prevent neuronal death induced by reactive oxygen and nitrogen species. Glia 1999; 28: 85-96.
12. Kramer-Hammerle S, Rothenaigner I, Wolff H, Bell JE, and Brack-Werner R. Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Res 2005; 111: 194-213.
13. Bell JE. An update on the neuropathology of HIV in the HAART era. Histopathology 2004; 45: 549-559.
14. Kaul M, Garden GA, Lipton SA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001; 410: 988-994.
15. Bajetto A, Bonavia R, Barbero S, Schettini G. Characterization of chemokines and their receptors in the central nervous system: physiopathological implications. J Neurochem 2002; 82: 1311-1329.
16. Gonzáles-Scarano F and Baltuch G, Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 1999; 22:219-40.
17. Chauhan A, Turchan J, Pocernich C, Bruce-Keller A, Roth S, Butterfield DA, Major EO, Nath A. Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport. J Biol Chem 2003; 278: 13512-13519.
18. Zhou BY, Liu Y, Kim B, Xiao Y, He JJ. Astrocyte activation and dysfunction and neuron death by HIV-1 Tat expression in astrocytes. Mol Cell Neurosci 2004; 27: 296-305.
19. Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, Morgan RA, Wingfield P, Gallo RC. Release, uptake, and effects of extracellular human immunodeficiency virus type-1 tat protein on cell growth and viral transactivation. J Virol 1993; 67:277-287.
20. Vitkovic L. and Tardieu M. Neuropathogenesis of HIV-1 infection. Outstanding questions. Acad Sci 1998;321: 1015-1021.
21. Maragakis NJ and Rothstein JD. Mechanisms of disease. Astrocytes in neurodegenerative disease. Nature 2006; 2: 679-689.
22. Giunta B, Zhou Y, Hou H, Rrapo E, Fernandez F, Tan J. HIV-1 Tat inhibits macroglial phagocytosis of AB peptide. Int J Clin Exp Pathol 2008; 1: 260-275.
23. Kim BO, Liu Y, Ruan Y, Xu ZC, Schantz L, He JJ. Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocytespecific glial fibrillary acidic protein promoter and doxycycline. Am J Pathol 2003; 162: 1693-1707.
24. Jones M, Olafson K, Del Bigio MR, Peeling J, Nath A. Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement. J Neuropathol Exp Neurol 1998; 57: 563-570.
25. Giunta B, Obregon D, Hou H, Zeng J, Sun N, NikolicV, Ehrhart J, Shytle D, Fernandez F, Tan J. EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-.: Role of JAK/STAT1 signaling and implications for HIV-associated dementia. Brain Res 2006; 1123: 216-225.
26. Vanzani MC, Iacono RF, Caccuri RL, Troncoso AR, Berria MI. Regional differences in astrocyte activation in HIV-associated dementia. Medicina 2006; 66: 108-112.
27. Saunders M, Eldeen MB, Del Valle L, Reiss K, Peruzzi F, Mameli G, Gelman BB, Khalili K, Amini S, Sawaya BE. p73 modulates HIV-1 Tat transcriptional and apoptotic activities in human astrocytes. Apoptosis 2005; 10: 1419-1431.
28. Amini S, Mameli G, Del Valle L, Skowronska A, Reiss K, Gelman BB, White MK, Khalili K, Sawaya BE. p73 interacts with human immunodeficiency virus type 1 Tat in astrocytic cells and prevents its acetylation on lysine 28. Molec Cell Biology 2005; 25: 8126-8138.
29. Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B, McArthur JC. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology 2001; 56: 257-260.
30. Everall IP, Heaton RK, Marcotte TD, Ellis RJ, McCutchan JA, Atkinson JH, Grant I, Mallory M, Masliah E. Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. Brain Pathol 1999; 9: 209-217.
31. Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, Achim CL, McCutchan JA, Nelson JA, Atkinson JH, Grant I. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. Ann Neurol 1997; 42: 963-972.